Trials / Conditions / Oropharyngeal Neoplasms

Oropharyngeal Neoplasms

24 registered clinical trials studyying Oropharyngeal Neoplasms — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Human Papillomavirus Association and Genomic Exploration in Head-Neck Squamous Cell Carcinomas NCT06642324	Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh	—
Recruiting	Phase II Randomized-registry Embedded Study of Lymphoscintigraphy for Oropharyngeal Neoplasms to Enable Risk-a NCT06167291	M.D. Anderson Cancer Center	Phase 2
Unknown	Investigating the Association Between Microbiota and Esophageal/Oropharyngeal Cancer NCT05412628	National Cheng-Kung University Hospital	N/A
Terminated	E7 TCR Cell Induction Immunotherapy for Stage II and Stage III HPV-Associated Oropharyngeal Cancer NCT04015336	National Cancer Institute (NCI)	Phase 2
Enrolling By Invitation	Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies NCT04266093	National Cancer Institute (NCI)	—
Withdrawn	A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I NCT04044950	National Cancer Institute (NCI)	Phase 2
Active Not Recruiting	Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma NCT04124198	Christian von Buchwald	N/A
Completed	Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact NCT03239834	Vigilant Biosciences, Inc.	—
Completed	A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery NCT03010813	Chinese University of Hong Kong	N/A
Completed	P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC NCT03077243	UNC Lineberger Comprehensive Cancer Center	Phase 2
Completed	Isocapnic Hyperventilation - an Alternative Method NCT03074110	Sahlgrenska University Hospital	N/A
Withdrawn	Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinoma NCT02298595	Julie E. Bauman, MD, MPH	Phase 1 / Phase 2
Completed	Robotic Surgery in the Seated Position for Benign and Malignant Lesions of the Head and Neck NCT02792322	Mayo Clinic	N/A
Completed	De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study NCT02281955	UNC Lineberger Comprehensive Cancer Center	Phase 2
Completed	A Post-Market Clinical Trial for Access and Visualization of the Oropharynx, Hypopharynx and Larynx During Tra NCT02262247	Medrobotics Corporation	—
Terminated	Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma NCT02045186	UNC Lineberger Comprehensive Cancer Center	N/A
Terminated	Post Operative Adjuvant Therapy De-intensification Trial for Human Papillomavirus-related, p16+ Oropharynx Can NCT01687413	Washington University School of Medicine	Phase 3
Completed	De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous NCT01530997	UNC Lineberger Comprehensive Cancer Center	Phase 2
Terminated	Study of Chemotherapy Prior to Radiotherapy and Chemotherapy in Patients With HPV Associated Cancer of the Ora NCT01525927	Northwell Health	Phase 2
Completed	Pharmacogenetic Response to Chemotherapy Induction for ORL Cancers NCT01104714	Centre Hospitalier Universitaire de Nīmes	—
Unknown	Human Papillomavirus and Oropharynx Carcinoma NCT00918710	Assistance Publique - Hôpitaux de Paris	—
Completed	F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients NCT00721799	University of Iowa	Phase 2
Unknown	Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcin NCT00251381	Trial Form Support S.L.	Phase 2
Unknown	Analgesia of Fibula Free Flap Donor Site by Peri-Neuronal Catheter in Oro-Pharyngeal Carcinoma Surgery NCT00181038	Gustave Roussy, Cancer Campus, Grand Paris	Phase 3